GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » EV-to-EBITDA

Psomagen (XKRX:950200) EV-to-EBITDA : -66.42 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Psomagen EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Psomagen's enterprise value is ₩86,591 Mil. Psomagen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,304 Mil. Therefore, Psomagen's EV-to-EBITDA for today is -66.42.

The historical rank and industry rank for Psomagen's EV-to-EBITDA or its related term are showing as below:

XKRX:950200' s EV-to-EBITDA Range Over the Past 10 Years
Min: -220.08   Med: -11.87   Max: 75.66
Current: -66.42

During the past 6 years, the highest EV-to-EBITDA of Psomagen was 75.66. The lowest was -220.08. And the median was -11.87.

XKRX:950200's EV-to-EBITDA is ranked worse than
100% of 112 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.38 vs XKRX:950200: -66.42

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), Psomagen's stock price is ₩4815.00. Psomagen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-94.000. Therefore, Psomagen's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Psomagen EV-to-EBITDA Historical Data

The historical data trend for Psomagen's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen EV-to-EBITDA Chart

Psomagen Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - -19.37 -46.98 45.73 -485.01

Psomagen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.73 29.39 38.09 68.60 -485.01

Competitive Comparison of Psomagen's EV-to-EBITDA

For the Diagnostics & Research subindustry, Psomagen's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psomagen's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psomagen's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Psomagen's EV-to-EBITDA falls into.



Psomagen EV-to-EBITDA Calculation

Psomagen's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=86591.022/-1303.649
=-66.42

Psomagen's current Enterprise Value is ₩86,591 Mil.
Psomagen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,304 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psomagen  (XKRX:950200) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Psomagen's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4815.00/-94.000
=At Loss

Psomagen's share price for today is ₩4815.00.
Psomagen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-94.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Psomagen EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Psomagen's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Psomagen (XKRX:950200) Business Description

Traded in Other Exchanges
N/A
Address
1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850
Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines